Cadent Capital Advisors LLC Acquires New Stake in iShares Biotechnology ETF $IBB

Cadent Capital Advisors LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, HoldingsChannel reports. The fund bought 20,676 shares of the financial services provider’s stock, valued at approximately $4,353,000. iShares Biotechnology ETF comprises about 0.9% of Cadent Capital Advisors LLC’s investment portfolio, making the stock its 29th biggest holding.

A number of other institutional investors have also modified their holdings of the business. IFP Advisors Inc increased its position in iShares Biotechnology ETF by 39.3% during the 2nd quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after purchasing an additional 14,115 shares during the period. Security National Bank of Sioux City Iowa IA boosted its stake in shares of iShares Biotechnology ETF by 31.8% in the second quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock valued at $2,318,000 after buying an additional 2,939 shares in the last quarter. Kestra Advisory Services LLC grew its holdings in iShares Biotechnology ETF by 12.2% during the first quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock worth $8,014,000 after acquiring an additional 5,155 shares during the period. The Manufacturers Life Insurance Company grew its holdings in iShares Biotechnology ETF by 64.0% during the second quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock worth $19,369,000 after acquiring an additional 39,760 shares during the period. Finally, Kera Capital Partners Inc. purchased a new position in iShares Biotechnology ETF in the fourth quarter worth $3,975,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB traded up $5.97 during trading on Friday, hitting $206.45. 1,223,384 shares of the company were exchanged, compared to its average volume of 1,647,692. iShares Biotechnology ETF has a 1 year low of $149.09 and a 1 year high of $217.12. The firm’s fifty day moving average price is $205.40 and its 200 day moving average price is $186.32.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were issued a $0.0112 dividend. The ex-dividend date was Tuesday, September 15th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.